Cytosorbents (CTSO) EBT Margin Growth (3y) (2014 - 2026)
Cytosorbents (CTSO) EBT Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 329.00 |
| 10 | Cytosorbents | 28.80 Mn | 24.00 Mn | 6.13 Mn | 3,352.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,352.00 |
| Dec 31, 2025 | -5,066.00 |
| Sep 30, 2025 | 11,277.00 |
| Jun 30, 2025 | 8,406.00 |
| Mar 31, 2025 | 8,622.00 |
| Dec 31, 2024 | -802.00 |
| Sep 30, 2024 | 3,350.00 |
| Jun 30, 2024 | -796.00 |
| Mar 31, 2024 | -2,841.00 |
| Dec 31, 2023 | 18,267.00 |
| Sep 30, 2023 | -9,638.00 |
| Jun 30, 2023 | -3,604.00 |
| Mar 31, 2023 | -3,787.00 |
| Dec 31, 2022 | 4,806.00 |
| Sep 30, 2022 | -3,745.00 |
| Jun 30, 2022 | -7,114.00 |
| Mar 31, 2022 | -909.00 |
| Dec 31, 2021 | 590.00 |
| Sep 30, 2021 | -1,331.00 |
| Jun 30, 2021 | 6,224.00 |